Relmada Therapeutics News, Relmada Therapeutics Quote, RLMD Quote

Relmada Therapeutics (NQ:RLMD) Delayed: 6.91 +0.26 (3.91%)

Prev. Close

$6.65

Today 6M 1Y 5Y

Open

$6.67

52 Wk High

$4.10

52 Wk Low

$0.87

Day High

$6.97

Day Low

$6.55

P/E

N/A

EPS

$0.00

Volume

1,431,672

Friends, Peers and Foes (?): ABL, ABM, ASTE, BHE, BZH (more...)

ALERTS | RSS

Jun 11, 2026 07:02 AM Relmada appoints Michael Quirk as senior advisor for sepranolone program
Jun 11, 2026 07:00 AM Relmada Therapeutics Appoints CNS Drug Development Veteran Michael Quirk as Senior Advisor for Sepranolone Program
Jun 9, 2026 08:04 PM Form SCHEDULE 13G RELMADA THERAPEUTICS, Filed by: Venrock Healthcare Capital Partners III, L.P.
May 28, 2026 05:50 PM Form 8-K RELMADA THERAPEUTICS, For: May 27
May 28, 2026 07:04 AM Relmada Therapeutics (RLMD) to Present at the Jefferies Global Healthcare Conference
May 28, 2026 07:00 AM Relmada Therapeutics to Present at the Jefferies Global Healthcare Conference
May 13, 2026 04:59 PM Relmada Therapeutics (RLMD) files mixed shelf
May 13, 2026 04:53 PM Form S-3ASR RELMADA THERAPEUTICS,
May 13, 2026 09:15 AM Form SCHEDULE 13G/A RELMADA THERAPEUTICS, Filed by: Adage Capital Management, L.P.
May 12, 2026 05:01 PM Form 8-K RELMADA THERAPEUTICS, For: May 12

Entities mentioned with RLMD

View All Entities